Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5913397 | Blood Cells, Molecules, and Diseases | 2016 | 5 Pages |
Abstract
For clinicians, it is important to recognize that effects of rhFVIIa within these pathways are independent of its contribution to blood clot formation and cannot be assessed by clotting assays. Reduced FVII levels should therefore not be dismissed, as even a mild reduction may result in spontaneous bleeding. Treatment of mild FVII deficiency requires a careful case-by-case approach, based on the clinical scenario.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Thomas J. Cramer, Kristin Anderson, Karanjia Navaz, Justin M. Brown, Laurent O. Mosnier, Annette von Drygalski,